Informing patients about drugs : summary report on alternative designs for prescription drug leaflets / David E. Kanouse.

Contributor(s):

Publisher: Santa Monica, CA : RAND, 1981Description: vii, 38 pages ; 28 cmContent type:

text

Media type:

computer
unmediated

Carrier type:

online resource
volume

ISBN:

0833003518

Subject(s):

Genre/Form:

Electronic books.

LOC classification:

RS58 .I534 1981

Online resources:

Click here to access online

Available additional physical forms:

Also available on the internet via WWW in PDF format.

Summary: The research reported is the most thorough investigation to date on the effects of patient package inserts (PPIs). Users of each of three prescription drugs (conjugated estrogens, erythromycin, and flurazepam hydrochloride) received one of several different prototype PPIs with their prescriptions and were subsequently interviewed by telephone. For two of the three drugs studied, the design provided a control group that received no PPI. The principal findings include: (1) PPIs are likely to be widely read; (2) patients learn from written drug information and find it helpful; (3) PPIs seem to have little effect on how patients use a drug; (4) warning patients about potential drug side effects does not, by itself, cause patients to experience these effects through suggestion; (5) there is little advantage to be gained by highlighting information about a drug's risks; and (6) the simplicity with which a PPI is written has surprisingly little effect.

Item type:

eBooks

Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 5 )

No physical items for this record

"August 1981."

Includes bibliographical references (p. 35-38).

The research reported is the most thorough investigation to date on the effects of patient package inserts (PPIs). Users of each of three prescription drugs (conjugated estrogens, erythromycin, and flurazepam hydrochloride) received one of several different prototype PPIs with their prescriptions and were subsequently interviewed by telephone. For two of the three drugs studied, the design provided a control group that received no PPI. The principal findings include: (1) PPIs are likely to be widely read; (2) patients learn from written drug information and find it helpful; (3) PPIs seem to have little effect on how patients use a drug; (4) warning patients about potential drug side effects does not, by itself, cause patients to experience these effects through suggestion; (5) there is little advantage to be gained by highlighting information about a drug's risks; and (6) the simplicity with which a PPI is written has surprisingly little effect.

Also available on the internet via WWW in PDF format.

Description based on print version record.